EVOLUS, INC. Operating Leases, Rent Expense
EVOLUS, INC. (EOLS) reported Operating Leases, Rent Expense of $334.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-02-25
- EVOLUS, INC. operating leases, rent expense for the quarter ending 2018-12-31 was $150.00K, a 82.93% increase year-over-year.
- EVOLUS, INC. operating leases, rent expense for the quarter ending 2018-09-30 was $66.00K, a 69.23% increase year-over-year.
- EVOLUS, INC. operating leases, rent expense for the quarter ending 2018-06-30 was $66.00K, a 73.68% increase year-over-year.
- EVOLUS, INC. operating leases, rent expense for the quarter ending 2018-03-31 was $52.00K, a 26.83% increase year-over-year.
- EVOLUS, INC. operating leases, rent expense for fiscal 2018 was $334.00K, a 67.00% increase from fiscal 2017.
- EVOLUS, INC. operating leases, rent expense for fiscal 2017 was $200.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $216.00K derived: sum of 2 quarters · filed 2020-02-25 | $282.00K derived: sum of 3 quarters · filed 2020-02-25 | $334.00K 10-K · filed 2020-02-25 | $300.00K 10-K · filed 2019-03-20 |
| 2018-09-30 | $66.00K 10-Q · filed 2018-11-05 | $132.00K derived: sum of 2 quarters · filed 2018-11-05 | $184.00K 10-Q · filed 2018-11-05 | $266.00K derived: sum of 4 quarters · filed 2019-03-20 | |
| 2018-06-30 | $66.00K 10-Q · filed 2018-08-02 | $118.00K 10-Q · filed 2018-08-02 | $200.00K derived: sum of 3 quarters · filed 2019-03-20 | $239.00K derived: sum of 4 quarters · filed 2019-03-20 | |
| 2018-03-31 | $52.00K 10-Q · filed 2018-05-10 | $134.00K derived: sum of 2 quarters · filed 2019-03-20 | $173.00K derived: sum of 3 quarters · filed 2019-03-20 | $211.00K derived: sum of 4 quarters · filed 2019-03-20 | |
| 2017-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $121.00K derived: sum of 2 quarters · filed 2019-03-20 | $159.00K derived: sum of 3 quarters · filed 2019-03-20 | $200.00K 10-K · filed 2019-03-20 | |
| 2017-09-30 | $39.00K 10-Q · filed 2018-11-05 | $77.00K derived: sum of 2 quarters · filed 2018-11-05 | $118.00K 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $38.00K 10-Q · filed 2018-08-02 | $79.00K 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $41.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |